JP2010516778A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010516778A5 JP2010516778A5 JP2009547368A JP2009547368A JP2010516778A5 JP 2010516778 A5 JP2010516778 A5 JP 2010516778A5 JP 2009547368 A JP2009547368 A JP 2009547368A JP 2009547368 A JP2009547368 A JP 2009547368A JP 2010516778 A5 JP2010516778 A5 JP 2010516778A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- hydroxy
- propyl
- enyl
- hexyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 (3-methylphenoxy) methyl Chemical group 0.000 claims 40
- 150000001875 compounds Chemical class 0.000 claims 15
- 125000004432 carbon atom Chemical group C* 0.000 claims 8
- 229910052731 fluorine Inorganic materials 0.000 claims 6
- 229910052760 oxygen Inorganic materials 0.000 claims 6
- 229910052794 bromium Inorganic materials 0.000 claims 5
- 229910052801 chlorine Inorganic materials 0.000 claims 5
- 239000000460 chlorine Substances 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 4
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 229910052740 iodine Inorganic materials 0.000 claims 4
- 125000001424 substituent group Chemical group 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 claims 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical group CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical class C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims 2
- QAUDZXQUXQZXMX-HSTJUUNISA-N 5-[3-[(1s)-2-[4-(1-hydroxyhexyl)phenyl]-3-(hydroxymethyl)cyclopent-2-en-1-yl]propyl]thiophene-2-carboxylic acid Chemical compound C1=CC(C(O)CCCCC)=CC=C1C1=C(CO)CC[C@@H]1CCCC1=CC=C(C(O)=O)S1 QAUDZXQUXQZXMX-HSTJUUNISA-N 0.000 claims 1
- DIBRODJJOHGAMF-AJZOCDQUSA-N 5-[3-[(1s)-2-[4-(1-hydroxyhexyl)phenyl]-3-methylcyclopent-2-en-1-yl]propyl]thiophene-2-carboxylic acid Chemical compound C1=CC(C(O)CCCCC)=CC=C1C1=C(C)CC[C@@H]1CCCC1=CC=C(C(O)=O)S1 DIBRODJJOHGAMF-AJZOCDQUSA-N 0.000 claims 1
- FURUXPWGYFPDDI-XNUZUHMRSA-N 5-[3-[(1s)-2-[4-(1-hydroxyhexyl)phenyl]cyclopent-2-en-1-yl]propyl]thiophene-2-carboxylic acid Chemical compound C1=CC(C(O)CCCCC)=CC=C1C1=CCC[C@@H]1CCCC1=CC=C(C(O)=O)S1 FURUXPWGYFPDDI-XNUZUHMRSA-N 0.000 claims 1
- FURUXPWGYFPDDI-FDDCHVKYSA-N 5-[3-[(1s)-2-[4-[(1r)-1-hydroxyhexyl]phenyl]cyclopent-2-en-1-yl]propyl]thiophene-2-carboxylic acid Chemical compound C1=CC([C@H](O)CCCCC)=CC=C1C1=CCC[C@@H]1CCCC1=CC=C(C(O)=O)S1 FURUXPWGYFPDDI-FDDCHVKYSA-N 0.000 claims 1
- FURUXPWGYFPDDI-MBSDFSHPSA-N 5-[3-[(1s)-2-[4-[(1s)-1-hydroxyhexyl]phenyl]cyclopent-2-en-1-yl]propyl]thiophene-2-carboxylic acid Chemical compound C1=CC([C@@H](O)CCCCC)=CC=C1C1=CCC[C@@H]1CCCC1=CC=C(C(O)=O)S1 FURUXPWGYFPDDI-MBSDFSHPSA-N 0.000 claims 1
- AWKGQLGTTLCSEX-HXBUSHRASA-N 5-[3-[(1s)-3-bromo-2-[4-(1-hydroxyhexyl)phenyl]cyclopent-2-en-1-yl]propyl]thiophene-2-carboxylic acid Chemical compound C1=CC(C(O)CCCCC)=CC=C1C1=C(Br)CC[C@@H]1CCCC1=CC=C(C(O)=O)S1 AWKGQLGTTLCSEX-HXBUSHRASA-N 0.000 claims 1
- GSSOHXXMKRUADR-HXBUSHRASA-N 5-[3-[(1s)-3-chloro-2-[4-(1-hydroxyhexyl)phenyl]cyclopent-2-en-1-yl]propyl]thiophene-2-carboxylic acid Chemical compound C1=CC(C(O)CCCCC)=CC=C1C1=C(Cl)CC[C@@H]1CCCC1=CC=C(C(O)=O)S1 GSSOHXXMKRUADR-HXBUSHRASA-N 0.000 claims 1
- GSSOHXXMKRUADR-PGRDOPGGSA-N 5-[3-[(1s)-3-chloro-2-[4-[(1r)-1-hydroxyhexyl]phenyl]cyclopent-2-en-1-yl]propyl]thiophene-2-carboxylic acid Chemical compound C1=CC([C@H](O)CCCCC)=CC=C1C1=C(Cl)CC[C@@H]1CCCC1=CC=C(C(O)=O)S1 GSSOHXXMKRUADR-PGRDOPGGSA-N 0.000 claims 1
- GSSOHXXMKRUADR-AVRDEDQJSA-N 5-[3-[(1s)-3-chloro-2-[4-[(1s)-1-hydroxyhexyl]phenyl]cyclopent-2-en-1-yl]propyl]thiophene-2-carboxylic acid Chemical compound C1=CC([C@@H](O)CCCCC)=CC=C1C1=C(Cl)CC[C@@H]1CCCC1=CC=C(C(O)=O)S1 GSSOHXXMKRUADR-AVRDEDQJSA-N 0.000 claims 1
- WXPDYICOSZKKNP-WMZHIEFXSA-N 5-[3-[(1s)-3-cyano-2-[4-[(1r)-1-hydroxyhexyl]phenyl]cyclopent-2-en-1-yl]propyl]thiophene-2-carboxylic acid Chemical compound C1=CC([C@H](O)CCCCC)=CC=C1C1=C(C#N)CC[C@@H]1CCCC1=CC=C(C(O)=O)S1 WXPDYICOSZKKNP-WMZHIEFXSA-N 0.000 claims 1
- WXPDYICOSZKKNP-CVDCTZTESA-N 5-[3-[(1s)-3-cyano-2-[4-[(1s)-1-hydroxyhexyl]phenyl]cyclopent-2-en-1-yl]propyl]thiophene-2-carboxylic acid Chemical compound C1=CC([C@@H](O)CCCCC)=CC=C1C1=C(C#N)CC[C@@H]1CCCC1=CC=C(C(O)=O)S1 WXPDYICOSZKKNP-CVDCTZTESA-N 0.000 claims 1
- QDJYYSGWZGMGOI-HXBUSHRASA-N 5-[3-[(1s)-3-fluoro-2-[4-(1-hydroxyhexyl)phenyl]cyclopent-2-en-1-yl]propyl]thiophene-2-carboxylic acid Chemical compound C1=CC(C(O)CCCCC)=CC=C1C1=C(F)CC[C@@H]1CCCC1=CC=C(C(O)=O)S1 QDJYYSGWZGMGOI-HXBUSHRASA-N 0.000 claims 1
- AWXZRMOMNDPJLB-LROBGIAVSA-N 5-[3-[(1s)-3-hydroxy-2-[4-(1-hydroxyhexyl)phenyl]-4-oxocyclopent-2-en-1-yl]propyl]thiophene-2-carboxylic acid Chemical compound C1=CC(C(O)CCCCC)=CC=C1C1=C(O)C(=O)C[C@@H]1CCCC1=CC=C(C(O)=O)S1 AWXZRMOMNDPJLB-LROBGIAVSA-N 0.000 claims 1
- WEZBMBFZDRGVBJ-HRKCMRQESA-N 5-[3-[(1s,2s)-3-bromo-2-[4-(1-hydroxyhexyl)phenyl]cyclopent-3-en-1-yl]propyl]thiophene-2-carboxylic acid Chemical compound C1=CC(C(O)CCCCC)=CC=C1[C@H]1C(Br)=CC[C@@H]1CCCC1=CC=C(C(O)=O)S1 WEZBMBFZDRGVBJ-HRKCMRQESA-N 0.000 claims 1
- ZKABQRINGXUDOC-ZSTBOYNDSA-N 5-[3-[(1s,2s)-3-cyano-2-[4-(1-hydroxyhexyl)phenyl]cyclopent-3-en-1-yl]propyl]thiophene-2-carboxylic acid Chemical compound C1=CC(C(O)CCCCC)=CC=C1[C@H]1C(C#N)=CC[C@@H]1CCCC1=CC=C(C(O)=O)S1 ZKABQRINGXUDOC-ZSTBOYNDSA-N 0.000 claims 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 208000010412 Glaucoma Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 206010030043 Ocular hypertension Diseases 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 235000010290 biphenyl Nutrition 0.000 claims 1
- 239000004305 biphenyl Substances 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 125000001246 bromo group Chemical group Br* 0.000 claims 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- SBODGBDAZDYMLH-XEGCMXMBSA-N methyl 5-[3-[(1s)-2-[4-(1-hydroxyhexyl)phenyl]-3-methylcyclopent-2-en-1-yl]propyl]thiophene-2-carboxylate Chemical compound C1=CC(C(O)CCCCC)=CC=C1C1=C(C)CC[C@@H]1CCCC1=CC=C(C(=O)OC)S1 SBODGBDAZDYMLH-XEGCMXMBSA-N 0.000 claims 1
- CRFWOBRSFBVPKW-YADARESESA-N methyl 5-[3-[(1s)-2-[4-[(1r)-1-hydroxyhexyl]phenyl]cyclopent-2-en-1-yl]propyl]thiophene-2-carboxylate Chemical compound C1=CC([C@H](O)CCCCC)=CC=C1C1=CCC[C@@H]1CCCC1=CC=C(C(=O)OC)S1 CRFWOBRSFBVPKW-YADARESESA-N 0.000 claims 1
- CRFWOBRSFBVPKW-CYFREDJKSA-N methyl 5-[3-[(1s)-2-[4-[(1s)-1-hydroxyhexyl]phenyl]cyclopent-2-en-1-yl]propyl]thiophene-2-carboxylate Chemical compound C1=CC([C@@H](O)CCCCC)=CC=C1C1=CCC[C@@H]1CCCC1=CC=C(C(=O)OC)S1 CRFWOBRSFBVPKW-CYFREDJKSA-N 0.000 claims 1
- JCNNJYAVSLYUPY-GBXCKJPGSA-N methyl 5-[3-[(1s)-3-cyano-2-[4-[(1r)-1-hydroxyhexyl]phenyl]cyclopent-2-en-1-yl]propyl]thiophene-2-carboxylate Chemical compound C1=CC([C@H](O)CCCCC)=CC=C1C1=C(C#N)CC[C@@H]1CCCC1=CC=C(C(=O)OC)S1 JCNNJYAVSLYUPY-GBXCKJPGSA-N 0.000 claims 1
- JCNNJYAVSLYUPY-RDPSFJRHSA-N methyl 5-[3-[(1s)-3-cyano-2-[4-[(1s)-1-hydroxyhexyl]phenyl]cyclopent-2-en-1-yl]propyl]thiophene-2-carboxylate Chemical compound C1=CC([C@@H](O)CCCCC)=CC=C1C1=C(C#N)CC[C@@H]1CCCC1=CC=C(C(=O)OC)S1 JCNNJYAVSLYUPY-RDPSFJRHSA-N 0.000 claims 1
- MRRIHVSTSQNLPJ-HSTJUUNISA-N methyl 5-[3-[(1s)-3-fluoro-2-[4-(1-hydroxyhexyl)phenyl]cyclopent-2-en-1-yl]propyl]thiophene-2-carboxylate Chemical compound C1=CC(C(O)CCCCC)=CC=C1C1=C(F)CC[C@@H]1CCCC1=CC=C(C(=O)OC)S1 MRRIHVSTSQNLPJ-HSTJUUNISA-N 0.000 claims 1
- HPGLSISULYMKES-JIFYIFHXSA-N methyl 5-[3-[(1s,2s)-3-cyano-2-[4-(1-hydroxyhexyl)phenyl]cyclopent-3-en-1-yl]propyl]thiophene-2-carboxylate Chemical compound C1=CC(C(O)CCCCC)=CC=C1[C@H]1C(C#N)=CC[C@@H]1CCCC1=CC=C(C(=O)OC)S1 HPGLSISULYMKES-JIFYIFHXSA-N 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 150000007524 organic acids Chemical group 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- VQJIFFIMMFKHHG-GVNKFJBHSA-N propan-2-yl 5-[3-[(1s)-2-[4-(1-hydroxyhexyl)phenyl]cyclopent-2-en-1-yl]propyl]thiophene-2-carboxylate Chemical compound C1=CC(C(O)CCCCC)=CC=C1C1=CCC[C@@H]1CCCC1=CC=C(C(=O)OC(C)C)S1 VQJIFFIMMFKHHG-GVNKFJBHSA-N 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000003831 tetrazolyl group Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88653307P | 2007-01-25 | 2007-01-25 | |
| US60/886,533 | 2007-01-25 | ||
| PCT/US2008/051568 WO2008091818A1 (en) | 2007-01-25 | 2008-01-21 | Substituted arylcyclopentenes as therapeutic agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010516778A JP2010516778A (ja) | 2010-05-20 |
| JP2010516778A5 true JP2010516778A5 (enExample) | 2011-03-10 |
| JP5432724B2 JP5432724B2 (ja) | 2014-03-05 |
Family
ID=39469432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009547368A Expired - Fee Related JP5432724B2 (ja) | 2007-01-25 | 2008-01-21 | 治療薬としての置換アリールシクロペンテン類 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8722726B2 (enExample) |
| EP (1) | EP2121609A1 (enExample) |
| JP (1) | JP5432724B2 (enExample) |
| AU (1) | AU2008208042B2 (enExample) |
| BR (1) | BRPI0807804A2 (enExample) |
| CA (1) | CA2676252A1 (enExample) |
| WO (1) | WO2008091818A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9365485B2 (en) | 2007-01-25 | 2016-06-14 | Allergan, Inc. | Substituted arylcyclopentenes as therapeutic agents |
| US7713968B2 (en) | 2008-04-24 | 2010-05-11 | Allergan, Inc. | Substituted arylcyclopentenes as therapeutic agents |
| KR20110095898A (ko) | 2008-11-20 | 2011-08-25 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 유기 화합물의 플루오르화 |
| US20100247606A1 (en) * | 2009-03-25 | 2010-09-30 | Allergan, Inc. | Intraocular sustained release drug delivery systems and methods for treating ocular conditions |
| US9150516B2 (en) | 2011-04-12 | 2015-10-06 | President And Fellows Of Harvard College | Fluorination of organic compounds |
| US9273083B2 (en) | 2012-09-26 | 2016-03-01 | President And Fellows Of Harvard College | Nickel fluorinating complexes and uses thereof |
| US9000032B2 (en) * | 2013-05-31 | 2015-04-07 | Allergan, Inc. | Substituted cyclopentenes as therapeutic agents |
| CN104418783B (zh) * | 2013-08-28 | 2020-08-07 | 江苏豪森药业集团有限公司 | 依折麦布sss异构体的制备方法 |
| US10759764B2 (en) | 2013-10-18 | 2020-09-01 | President And Fellows Of Harvard College | Fluorination of organic compounds |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4066834A (en) | 1974-01-24 | 1978-01-03 | Miles Laboratories, Inc. | Cycloalkenyl analogues of prostaglandins E |
| US4066849A (en) * | 1976-06-11 | 1978-01-03 | Koss Corporation | Rotary-type control for headphone earpiece |
| KR100345943B1 (ko) | 1993-12-20 | 2002-11-30 | 후지사와 야꾸힝 고교 가부시키가이샤 | 4,5-디아릴옥사졸유도체 |
| US5462968A (en) * | 1994-01-19 | 1995-10-31 | Allergan, Inc. | EP2 -receptor agonists as agents for lowering intraocular pressure |
| US5902726A (en) | 1994-12-23 | 1999-05-11 | Glaxo Wellcome Inc. | Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma |
| AUPO713297A0 (en) * | 1997-06-02 | 1997-06-26 | Fujisawa Pharmaceutical Co., Ltd. | Oxazole compound |
| US5877211A (en) * | 1997-11-21 | 1999-03-02 | Allergan | EP2 receptor agonists as neuroprotective agents for the eye |
| AUPP608898A0 (en) * | 1998-09-23 | 1998-10-15 | Fujisawa Pharmaceutical Co., Ltd. | New use of prostaglandin E2 antagonists |
| GB0329620D0 (en) | 2003-12-22 | 2004-01-28 | Pharmagene Lab Ltd | EP2 receptor agonists |
| US7091231B2 (en) * | 2004-12-10 | 2006-08-15 | Allergan, Inc. | 12-Aryl prostaglandin analogs |
-
2008
- 2008-01-21 US US12/524,305 patent/US8722726B2/en not_active Expired - Fee Related
- 2008-01-21 EP EP08727980A patent/EP2121609A1/en not_active Withdrawn
- 2008-01-21 BR BRPI0807804-1A2A patent/BRPI0807804A2/pt not_active IP Right Cessation
- 2008-01-21 AU AU2008208042A patent/AU2008208042B2/en not_active Ceased
- 2008-01-21 JP JP2009547368A patent/JP5432724B2/ja not_active Expired - Fee Related
- 2008-01-21 WO PCT/US2008/051568 patent/WO2008091818A1/en not_active Ceased
- 2008-01-21 CA CA002676252A patent/CA2676252A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010516778A5 (enExample) | ||
| AU2007261034B2 (en) | Therapeutic compounds | |
| JP2009541340A5 (enExample) | ||
| AU2007248119B2 (en) | 12-aryl or heteroaryl prostaglandin analogs | |
| AU2007286177B2 (en) | Therapeutic lactams | |
| JP2009543795A5 (enExample) | ||
| JP2009543794A5 (enExample) | ||
| CA2660396A1 (en) | Therapeutic amides and related compounds | |
| AU2007249443B2 (en) | Isothiazolidines useful in the treatment of ocular hypertensive conditions | |
| AU2007248180A1 (en) | Cyclopentane-derivatives and their use as ocular hypotensive agents | |
| JP2011510085A5 (enExample) | ||
| AU2007286135B2 (en) | N-aryl or N-heteroaryl pyrazolidine and pyrazolidinone derivatives as prostaglandine receptor inhibitors | |
| EP2057128A2 (en) | Therapeutic substituted hydantoins and related compounds | |
| AU2007286756B2 (en) | Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds | |
| EP2331521B1 (en) | Compounds for growing hair | |
| CA2653223A1 (en) | Therapeutic pyrrolidine compounds | |
| CA2678191A1 (en) | Gamma-lactams for the treatment of glaucoma or elevated intraocular pressure | |
| AU2008208032A1 (en) | Substituted arylcylopentenes as therapeutic agents | |
| US20150274658A1 (en) | Therapeutic lactams |